• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《2008年中国乳腺癌发病、死亡和患病情况的估计与预测》

[Estimates and prediction on incidence, mortality and prevalence of breast cancer in China, 2008].

作者信息

Zhang Min-Lu, Huang Zhe-Zhou, Zheng Ying

机构信息

Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China.

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Oct;33(10):1049-51.

PMID:23290849
Abstract

OBJECTIVE

To estimate the incidence, mortality and 5-year prevalence of breast cancer in China, in 2008.

METHODS

Data from 36 cancer registries and the Third National Death Survey in China (2004 - 2005) were used to estimate the incidence, mortality and 5-year prevalence of breast cancer in China in 2008. Mathematical models were used to predict the breast cancer incidence and mortality in the next 20 years.

RESULTS

In 2008, the incidence of breast cancer was 169 452 (14.2%) with the incidence rate of 21.6/100 000, ranking the second among all the cancers. Deaths due to breast cancer was 44 908 (6.1%) with mortality as 5.7/100 000, which ranked the sixth among all the cancers. The 5-year prevalence rate of breast cancer in China was 120.8/100 000, taking up the proportion as 26.1%, ranking the first among all the cancers. Breast cancer was seen more frequently among people aged between 40 to 70. Our data on prediction showed that the incidence and mortality of breast cancer in China would gradually increase in the next 20 years.

CONCLUSION

Breast cancer was the second cause of incidence rates among all the cancers in China, with both increasing incidence and mortality. Population at most risk for breast cancer were those aged 40 to 70, who deserved special programs for prevention and control.

摘要

目的

估算2008年中国乳腺癌的发病率、死亡率及5年患病率。

方法

采用来自中国36个癌症登记处的数据以及第三次全国死因调查(2004 - 2005年)的数据,估算2008年中国乳腺癌的发病率、死亡率及5年患病率。运用数学模型预测未来20年乳腺癌的发病率和死亡率。

结果

2008年,乳腺癌发病数为169452例(占14.2%),发病率为21.6/10万,在所有癌症中位居第二。乳腺癌死亡数为44908例(占6.1%),死亡率为5.7/10万,在所有癌症中位居第六。中国乳腺癌的5年患病率为120.8/10万,占比26.1%,在所有癌症中位居第一。乳腺癌在40至70岁人群中更为常见。我们的预测数据显示,未来20年中国乳腺癌的发病率和死亡率将逐渐上升。

结论

乳腺癌是中国所有癌症中发病率第二高的病因,发病率和死亡率均呈上升趋势。乳腺癌风险最高的人群是40至70岁的人群,他们应得到专门的防控项目。

相似文献

1
[Estimates and prediction on incidence, mortality and prevalence of breast cancer in China, 2008].《2008年中国乳腺癌发病、死亡和患病情况的估计与预测》
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Oct;33(10):1049-51.
2
[Estimates and prediction on incidence, mortality and prevalence of lung cancer in China in 2008].[2008年中国肺癌发病、死亡和患病情况的估计与预测]
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Apr;33(4):391-4.
3
[Estimation and prediction of incidence, mortality and prevalence on liver cancer, in 2008, China].[2008年中国肝癌发病率、死亡率及患病率的估计与预测]
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jun;33(6):554-7.
4
[Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008].《2008年中国前列腺癌发病率、死亡率及患病率的估计与预测》
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Oct;33(10):1056-9.
5
[Estimates and prediction on incidence, mortality and prevalence of brain and neurologic tumors in China, 2008].[2008年中国脑及神经系统肿瘤发病率、死亡率和患病率的估计与预测]
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Oct;33(10):1060-3.
6
[Estimation and prediction for incidence, mortality and prevalence of common gastrointestinal tract cancers in China, in 2008].[2008年中国常见胃肠道癌症发病率、死亡率及患病率的估计与预测]
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Oct;33(10):1052-5.
7
[Time trends, estimates and projects for breast cancer incidence and mortality in China].[中国乳腺癌发病率和死亡率的时间趋势、估计及预测]
Zhonghua Zhong Liu Za Zhi. 2006 Jun;28(6):438-40.
8
[Estimation and prediction on cancer related incidence and mortality in China, 2008].[2008年中国癌症相关发病率和死亡率的估计与预测]
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jan;33(1):57-61.
9
[The incidence and mortality trends of female breast cancer in Beijing, China: between 2004 and 2008].[2004年至2008年中国北京女性乳腺癌的发病率和死亡率趋势]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Nov;46(11):1009-14.
10
[Incidence, mortality and survival rates of female breast cancer in Tianjin, China].[中国天津女性乳腺癌的发病率、死亡率和生存率]
Zhonghua Zhong Liu Za Zhi. 2002 Nov;24(6):573-5.

引用本文的文献

1
Exposure to Polybrominated Diphenyl Ethers and Phthalates in China: A Disease Burden and Cost Analysis.中国多溴二苯醚和邻苯二甲酸盐的暴露:疾病负担与成本分析
Toxics. 2022 Dec 8;10(12):766. doi: 10.3390/toxics10120766.
2
Nonpalpable breast masses: One-year ultrasound follow-up and morbidity outcomes in Shanghai.触诊阴性乳腺肿块:上海一年的超声随访和发病结果。
Medicine (Baltimore). 2020 Dec 11;99(50):e23556. doi: 10.1097/MD.0000000000023556.
3
Predictive Value of CD44 for Prognosis in Patients with Breast Cancer.CD44 对乳腺癌患者预后的预测价值。
Asian Pac J Cancer Prev. 2020 Sep 1;21(9):2561-2567. doi: 10.31557/APJCP.2020.21.9.2561.
4
Expression of miR-129-5p and miR-433 in the serum of breast cancer patients and their relationship with clinicopathological features.miR-129-5p和miR-433在乳腺癌患者血清中的表达及其与临床病理特征的关系。
Oncol Lett. 2020 Sep;20(3):2771-2778. doi: 10.3892/ol.2020.11827. Epub 2020 Jul 8.
5
Estradiol promotes the progression of ER+ breast cancer through methylation-mediated RSK4 inactivation.雌二醇通过甲基化介导的RSK4失活促进雌激素受体阳性(ER+)乳腺癌的进展。
Onco Targets Ther. 2019 Jul 22;12:5907-5916. doi: 10.2147/OTT.S208988. eCollection 2019.
6
[Key technologies in digital breast tomosynthesis system:theory, design, and optimization].[数字乳腺断层合成系统中的关键技术:理论、设计与优化]
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Feb 28;39(2):192-200. doi: 10.12122/j.issn.1673-4254.2019.09.11.
7
Efficacy and safety of compound Kushen injection combined with chemotherapy on postoperative Patients with breast cancer: A meta-analysis of randomized controlled trials.复方苦参注射液联合化疗对乳腺癌术后患者的疗效及安全性:一项随机对照试验的Meta分析
Medicine (Baltimore). 2019 Jan;98(3):e14024. doi: 10.1097/MD.0000000000014024.
8
Thirty Years Cancer Incidence Data for Lahore, Pakistan: Trends and Patterns 1984-2014.巴基斯坦拉合尔30年癌症发病率数据:1984 - 2014年的趋势与模式
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):709-717. doi: 10.22034/APJCP.2018.19.3.709.
9
Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer.细胞毒性T淋巴细胞相关抗原4的表达预示着管腔B型HER2阴性乳腺癌的预后不良。
Oncol Lett. 2018 Apr;15(4):5093-5097. doi: 10.3892/ol.2018.7991. Epub 2018 Feb 7.
10
Preliminary effectiveness of breast cancer screening among 1.22 million Chinese females and different cancer patterns between urban and rural women.中国 122 万女性乳腺癌筛查的初步效果及城乡女性不同的癌症发病模式。
Sci Rep. 2016 Dec 20;6:39459. doi: 10.1038/srep39459.